V. Mudaly

Improved Treatment Outcomes With Bedaquiline When Substituted for Second-line Injectable Agents in Multidrug-resistant Tuberculosis: A Retrospective Cohort Study.

N. Tiffin, Ying Zhao, G. Meintjes, 2018, Clinical infectious diseases : an official publication of the Infectious Diseases Society of America.

Adverse drug reactions in South African patients receiving bedaquiline-containing tuberculosis treatment: an evaluation of spontaneously reported cases

G. Maartens, Jackie Jones, K. Cohen, 2019, BMC Infectious Diseases.

Risk Factors for Coronavirus Disease 2019 (COVID-19) Death in a Population Cohort Study from the Western Cape Province, South Africa

L. Morris, M. Mendelson, G. Maartens, 2020, Clinical infectious diseases : an official publication of the Infectious Diseases Society of America.

HIV and covid-19 in South Africa

J. Freer, V. Mudaly, 2022, BMJ.

Diagnosis patterns for rifampicin-resistant TB after onset of COVID-19

V. Scott, D. Hacking, J. Furin, 2021, The international journal of tuberculosis and lung disease : the official journal of the International Union against Tuberculosis and Lung Disease.

Injectable-free regimens containing bedaquiline, delamanid, or both for adolescents with rifampicin-resistant tuberculosis in Khayelitsha, South Africa

P. Isaakidis, A. Garcia-Prats, J. Furin, 2020, EClinicalMedicine.

Tuberculosis Diagnosis and Preventive Monotherapy Among Children and Adolescents Exposed to Rifampicin-Resistant Tuberculosis in the Household

H. Cox, P. Isaakidis, S. Mathee, 2023, Open forum infectious diseases.

Outcomes of Children Born to Pregnant Women With Drug-resistant Tuberculosis Treated With Novel Drugs in Khayelitsha, South Africa: A Report of Five Patients

M. Loveday, J. Furin, J. Daniels, 2021, The Pediatric infectious disease journal.

Tuberculosis preventive therapy for children and adolescents: an emergency response to the COVID-19 pandemic

P. Isaakidis, S. Mathee, C. Pfaff, 2021, The Lancet Child & Adolescent Health.